Methods for prediction of peptide binding to MHC molecules: A comparative study

Molecular Medicine

Volumn 8, Issue 3, 2002, Pages 137-148

  Yu, Kun ^a   Petrovsky, Nikolai ^a   Schönbach, Christian ^a   Koh, Judice L Y ^a   Brusic, Vladimir ^a  

^a NONE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ALLELE; ARTICLE; ARTIFICIAL NEURAL NETWORK; BINDING AFFINITY; BIOINFORMATICS; CLINICAL IMMUNOLOGY; DRUG DESIGN; MAJOR HISTOCOMPATIBILITY COMPLEX; MASS SCREENING; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; T LYMPHOCYTE;

EID: 0036042580     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402006     Document Type: Article

References (49)

1. MHC ligands and peptide motifs: 1st listing
2. MHCPEP - A database of MHC-binding peptides: Update 1997
3. Human tumor antigens for cancer vaccine development
4. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
5. Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections
6. Computational binding assays of antigenic peptides
7. HLA-B15 peptide ligands are preferentially anchored at their C termini
8. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide sidechains
9. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning
10. Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues
11. Class II MHC quantitative binding motifs derived from a large molecular database with a versatile iterative stepwise discriminant analysis meta-algorithm
12. SYFPEITHI: Database for MHC ligands and peptide motifs
13. Prediction of MHC binding peptides using artificial neural networks
14. Prediction of binding to MHC class I molecules
15. Two complementary methods for predicting peptides binding major histocompatibility complex molecules
16. Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network
17. Predicting peptides that bind to MHC molecules using supervised learning of hidden Markov models
18. Selection of peptides that bind to the HLA-A2.1 molecule by molecular modeling
19. Predicting binding affinities of protein ligands from three-dimensional models: Application to peptide binding to class I major histocompatibility proteins
20. Toward the quantitative prediction of T-cell epitopes: coMFA and coMSIA studies of peptides with affinity for the class I MHC molecule HLA-A*0201
21. Structural principles that govern the peptide-binding motifs of class I MHC molecules
22. An empirical method for the prediction of T-cell epitopes
23. Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection
24. Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11
25. The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitopes recognized by cytotoxic T lymphocytes
26. Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells
27. Neural network-based prediction peptides binding major histocompatibility complex molecules
28. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): Evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes
29. Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithm
30. Cutting edge: Identification of novel T cell epitopes in Lol p5a by computational prediction
31. Statistical comparison of established T-cell epitope predictors against a large database of human and murine antigens
32. Specific and general HLA-DR binding motifs: Comparison of algorithms
33. Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules
34. Learning internal representation by error propagation
35. Hidden Markov models for sequence analysis: Extension and analysis of the basic method
36. Hidden Markov models in computational biology. Applications to protein modeling
37. HMMer user's guide (version 2.1.1)
38. Efficient discovery of immune response targets by cyclical refinement of QSAR models of peptide binding
39. Measuring the accuracy of diagnostic systems
40. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins
41. The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2
42. Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach
43. Phenotypic analysis of antigen-specific T lymphocytes
44. Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity
45. Mimotopes for tumor-specific T lymphocytes in human cancer determined with combinatorial peptide libraries